Back to Journals » OncoTargets and Therapy » Volume 8

The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies

Total article views   Abstract views HTML views PDF downloads Totals
7,764 Dovepress* 4,711 2,579+ 1,376 7,290
PubMed Central* 0 474 128 474
Totals 4,711 3,053 1,504 7,764
*Since 8 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar